145 related articles for article (PubMed ID: 27900988)
21. Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma.
Hayden AR; Lee DG; Villa D; Gerrie AS; Scott DW; Slack GW; Sehn LH; Connors JM; Savage KJ
Br J Haematol; 2020 Apr; 189(1):122-127. PubMed ID: 31822034
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites.
Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Barbounis A; Grigorakis V; Karkantaris C; Anargyrou K; Chatziioannou M; Rombos J; Boussiotis VA; Vaiopoulos G; Kittas C; Pangalis GA
Eur J Haematol; 2001; 67(5-6):279-88. PubMed ID: 11872075
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of Clinical Characteristics and Prognostic Factors of 223 Newly Diagnosed Hodgkin's Lymphoma Patients].
Liu S; Ma J; Yue YF; Li Q; Yang HL; Yu Y; Wang XF; Zhao ZG; Zhang YZ; Wang YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1296-300. PubMed ID: 26524026
[TBL] [Abstract][Full Text] [Related]
24. IPS-3 Validation in 1012 cases with classical hodgkin lymphoma.
Paydas S; Laçin S; Doğan M; Barista I; Yildiz B; Seydaoglu G; Karadurmus N; Civriz S; Kaplan MA; Yagci M; Gurkan E; Ercolak V
Leuk Res; 2021 Mar; 102():106519. PubMed ID: 33556744
[TBL] [Abstract][Full Text] [Related]
25. Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Sasse S; Goergen H; Plütschow A; Böll B; Eichenauer DA; Fuchs M; Behringer K; Zijlstra JM; Greil R; Markova J; Topp MS; Meissner J; Neubauer A; Baues C; Engert A; Borchmann P; von Tresckow B
J Clin Oncol; 2018 Sep; 36(25):2603-2611. PubMed ID: 29989855
[TBL] [Abstract][Full Text] [Related]
26. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
[TBL] [Abstract][Full Text] [Related]
27. Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.
Advani RH; Hoppe RT; Maeda LS; Baer DM; Mason J; Rosenberg SA; Horning SJ
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1374-9. PubMed ID: 20934280
[TBL] [Abstract][Full Text] [Related]
28. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
Logsdon MD; Ha CS; Kavadi VS; Cabanillas F; Hess MA; Cox JD
Cancer; 1997 Aug; 80(3):477-88. PubMed ID: 9241082
[TBL] [Abstract][Full Text] [Related]
29. Stage III follicular lymphoma: long-term follow-up and patterns of failure.
Ha CS; Kong JS; McLaughlin P; Tucker SL; Fayad LE; Hess MA; Wilder RB; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):748-54. PubMed ID: 14529780
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
31. [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].
Tao Y; Kang S; Zhou L; Shi Y; Li Y; Sun Y
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):466-71. PubMed ID: 26463153
[TBL] [Abstract][Full Text] [Related]
32. Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas.
Maucort-Boulch D; Djeridane M; Roy P; Riche B; Colonna P; Andrieu JM
Cancer; 2007 Jan; 109(2):256-64. PubMed ID: 17154164
[TBL] [Abstract][Full Text] [Related]
33. Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant.
Elshenawy MA; Shahzad Rauf M; Elhassan TAM; Maghfoor I; Akhtar S
Ann Hematol; 2018 Jul; 97(7):1229-1240. PubMed ID: 29484455
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
Santisteban-Espejo A; Perez-Requena J; Atienza-Cuevas L; Moran-Sanchez J; Fernandez-Valle MDC; Bernal-Florindo I; Romero-Garcia R; Garcia-Rojo M
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960792
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma].
Fu ZY; Zhu J; Song YQ; Liu WP; Ji XQ; Zhan SY
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):405-11. PubMed ID: 24943019
[TBL] [Abstract][Full Text] [Related]
36. How to define intermediate stage in Hodgkin's lymphoma?
Gisselbrecht C; Mounier N; André M; Casanovas O; Reman O; Sebban C; Divine M; Brice P; Briere J; Hennequin C; Fermé C
Eur J Haematol Suppl; 2005 Jul; (66):111-4. PubMed ID: 16007878
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
38. Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma.
Rautert R; Schinköthe T; Franklin J; Weihrauch M; Boll B; Pogge E; Bredenfeld H; Engert A; Diehl V; Re D
Leuk Lymphoma; 2008 Nov; 49(11):2091-8. PubMed ID: 19021051
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Factors for Clinical Outcomes in Patients with Newly Diagnosed Advanced-stage Hodgkin Lymphoma: A Nationwide Retrospective Study.
Jerry Teng CL; Tan TD; Pan YY; Lin YW; Lien PW; Chou HC; Chen PH; Lin FJ
Cancer Control; 2022; 29():10732748221124865. PubMed ID: 36134681
[TBL] [Abstract][Full Text] [Related]
40. Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan.
Itoh K; Kinoshita T; Watanabe T; Yoshimura K; Okamoto R; Chou T; Ogura M; Hirano M; Asaoku H; Kurosawa M; Maeda Y; Omachi K; Moriuchi Y; Kasai M; Ohnishi K; Takayama N; Morishima Y; Tobinai K; Kaba H; Yamamoto S; Fukuda H; Kikuchi M; Yoshino T; Matsuno Y; Hotta T; Shimoyama M
Int J Hematol; 2010 Apr; 91(3):446-55. PubMed ID: 20198461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
